From: MAIT cell counts are associated with the risk of hospitalization in COPD
Independent variables | Level of effect | Regression coefficient | Lower CL 95% | Upper CL 95% | p-value |
---|---|---|---|---|---|
Model 1 | |||||
Intercept | n.a | 4.988 | 2.176 | 7.800 | 0.001 |
Baseline FEV1 (% predicted) | n.a | − 0.007 | − 0.053 | 0.040 | 0.775 |
MAIT cell count (× 106/L) | n.a | − 0.061 | − 0.135 | 0.013 | 0.108 |
GOLD 2017 group | 1 (group A) | − 5.442 | − 6.539 | − 4.346 | < 0.001 |
GOLD 2017 group | 2 (group B) | − 5.081 | − 6.097 | − 4.064 | < 0.001 |
GOLD 2017 group | 3 (group C) | 13.412 | n.a | n.a | n.a |
ICS use (yes 1/no 0) | n.a | − 0.649 | − 1.411 | 0.113 | 0.095 |
Model 2 | |||||
Intercept | n.a | 3.562 | 0.400 | 6.724 | 0.027 |
Baseline FEV1 (% predicted) | n.a | − 0.016 | − 0.065 | 0.033 | 0.526 |
CD38 + (% of MAIT cells) | n.a | 0.221 | 0.076 | 0.367 | 0.003 |
GOLD 2017 group | 1 (group A) | − 5.530 | − 6.644 | − 4.417 | < 0.001 |
GOLD 2017 group | 2 (group B) | − 5.957 | − 7.052 | − 4.862 | < 0.001 |
GOLD 2017 group | 3 (group C) | 14.571 | n.a | n.a | n.a |
ICS use (yes 1/no 0) | n.a | − 0.815 | − 1.737 | 0.108 | 0.084 |
Model 3 | |||||
Intercept | n.a | 1.427 | − 2.983 | 5.838 | 0.526 |
Baseline FEV1 (% predicted) | n.a | 0.009 | − 0.053 | 0.070 | 0.782 |
LAG-3 + (% of MAIT cells) | n.a | 0.889 | 0.321 | 1.457 | 0.002 |
GOLD 2017 group | 1 (group A) | − 7.986 | − 10.033 | − 5.938 | < 0.001 |
GOLD 2017 group | 2 (group B) | − 5.387 | − 6.641 | − 4.113 | < 0.001 |
GOLD 2017 group | 3 (group C) | 16.024 | n.a | n.a | n.a |
ICS use (yes 1/no 0) | n.a | − 1.537 | − 2.756 | − 0.317 | 0.014 |